Scenesse OverviewAfamelanotide (melanotan I, brand name Scenesse) is a synthetic peptide and analogue of α-melanocyte stimulating hormone used to prevent skin damage from the sun in people with erythropoietic protoporphyria in Europe since January 2015, and the United States since October 2019. As a medicine sold under the brand name "Scenesse", it is administered in subcutaneous implant form; the implant lasts for two months. It is under development in other skin disorders in several jurisdictions. I...
Read more Scenesse Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Afamelanotide
Recent Scenesse Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Implant: 16mg